ACAD8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.191600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.166400E-01
Normal-vs-Stage2
2.649800E-02
Normal-vs-Stage3
1.853780E-02
Normal-vs-Stage4
2.344600E-01
Stage1-vs-Stage2
1.712970E-01
Stage1-vs-Stage3
2.339600E-02
Stage1-vs-Stage4
2.531400E-01
Stage2-vs-Stage3
3.105800E-02
Stage2-vs-Stage4
7.731600E-01
Stage3-vs-Stage4
3.059600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.597600E-02
Normal-vs-AfricanAmerican
3.859000E-01
Normal-vs-Asian
7.937800E-02
Caucasian-vs-AfricanAmerican
4.941600E-01
Caucasian-vs-Asian
5.378400E-01
AfricanAmerican-vs-Asian
4.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.569780E-02
Normal-vs-Female
1.341410E-01
Male-vs-Female
2.331200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.300000E-01
Normal-vs-Age(41-60Yrs)
2.539800E-02
Normal-vs-Age(61-80Yrs)
8.264400E-02
Normal-vs-Age(81-100Yrs)
5.857900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.685600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.109200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.117000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.858400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.180200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.368200E-02
Normal-vs-Daily Drinker
7.974200E-02
Normal-vs-Weekly Drinker
4.502000E-02
Normal-vs-Occasional Drinker
4.411200E-01
Normal-vs-Social Drinker
2.839700E-02
Non Drinker-vs-Daily Drinker
9.117600E-01
Non Drinker-vs-Weekly Drinker
6.321400E-01
Non Drinker-vs-Occasional Drinker
5.103600E-01
Non Drinker-vs-Social Drinker
9.582800E-01
Daily Drinker-vs-Weekly Drinker
7.591800E-01
Daily Drinker-vs-Occasional Drinker
4.950200E-01
Daily Drinker-vs-Social Drinker
8.905200E-01
Weekly Drinker-vs-Occasional Drinker
3.784400E-01
Weekly Drinker-vs-Social Drinker
6.175600E-01
Occasional Drinker-vs-Social Drinker
5.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.861800E-01
Normal-vs-Grade 2
7.664200E-02
Normal-vs-Grade 3
7.428400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.228000E-01
Grade 1-vs-Grade 3
6.499200E-01
Grade 1-vs-Grade 4
3.861800E-01
Grade 2-vs-Grade 3
6.165600E-01
Grade 2-vs-Grade 4
7.664200E-02
Grade 3-vs-Grade 4
7.428400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.895800E-03
Normal-vs-NonDiabetic
6.759500E-02
Diabetic-vs-NonDiabetic
1.437750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.083600E-01
Normal-vs-NoPancreatitis
3.634300E-02
Pancreatitis-vs-NoPancreatitis
1.656990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.097200E-01
Normal-vs-N1
1.944210E-02
N0-vs-N1
4.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.603000E-01
Normal-vs-TP53-NonMutant
3.294600E-01
TP53-Mutant-vs-TP53-NonMutant
2.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
